BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 28493612)

  • 1. Identification of extracellular matrix protein 1 as a potential plasma biomarker of ESCC by proteomic analysis using iTRAQ and 2D-LC-MS/MS.
    Wang X; Peng Y; Xie M; Gao Z; Yin L; Pu Y; Liu R
    Proteomics Clin Appl; 2017 Sep; 11(9-10):. PubMed ID: 28493612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma.
    Tong YS; Wang XW; Zhou XL; Liu ZH; Yang TX; Shi WH; Xie HW; Lv J; Wu QQ; Cao XF
    Mol Cancer; 2015 Jan; 14():3. PubMed ID: 25608466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of potential plasma biomarkers for esophageal squamous cell carcinoma by a proteomic method.
    Zhao J; Fan YX; Yang Y; Liu DL; Wu K; Wen FB; Zhang CY; Zhu DY; Zhao S
    Int J Clin Exp Pathol; 2015; 8(2):1535-44. PubMed ID: 25973038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tubulin beta chain, filamin A alpha isoform 1, and cytochrome b-c1 complex subunit 1 as serological diagnostic biomarkers of esophageal squamous cell carcinoma: a proteomics study.
    Fan NJ; Gao CF; Wang XL
    OMICS; 2013 Apr; 17(4):215-23. PubMed ID: 23496306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma.
    Cheng J; Jin H; Hou X; Lv J; Gao X; Zheng G
    Biochem Biophys Res Commun; 2017 May; 486(3):781-787. PubMed ID: 28342863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SILAC-based quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome.
    Kashyap MK; Harsha HC; Renuse S; Pawar H; Sahasrabuddhe NA; Kim MS; Marimuthu A; Keerthikumar S; Muthusamy B; Kandasamy K; Subbannayya Y; Prasad TS; Mahmood R; Chaerkady R; Meltzer SJ; Kumar RV; Rustgi AK; Pandey A
    Cancer Biol Ther; 2010 Oct; 10(8):796-810. PubMed ID: 20686364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. iTRAQ and two-dimensional-LC-MS/MS reveal NAA10 is a potential biomarker in esophageal squamous cell carcinoma.
    Wang D; Chen J; Han J; Wang K; Fang W; Jin J; Xue S
    Proteomics Clin Appl; 2022 May; 16(3):e2100081. PubMed ID: 35182098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma microRNA-19a as a potential biomarker for esophageal squamous cell carcinoma diagnosis and prognosis.
    Bai Y; Lin H; Fang Z; Luo Q; Fang Y; Su Y; Hu Q; Duan H; Chen F; Zhang ZY
    Biomark Med; 2017 May; 11(5):431-441. PubMed ID: 28621611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel circulating peptide biomarkers for esophageal squamous cell carcinoma revealed by a magnetic bead-based MALDI-TOFMS assay.
    Jia K; Li W; Wang F; Qu H; Qiao Y; Zhou L; Sun Y; Ma Q; Zhao X
    Oncotarget; 2016 Apr; 7(17):23569-80. PubMed ID: 26993605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. iTRAQ-based quantitative proteomic analysis of esophageal squamous cell carcinoma.
    Deng F; Zhou K; Li Q; Liu D; Li M; Wang H; Zhang W; Ma Y
    Tumour Biol; 2016 Feb; 37(2):1909-18. PubMed ID: 26330293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of plasma metabolomic profiling for diagnosis of esophageal squamous-cell carcinoma using an UPLC/TOF/MS platform.
    Liu R; Peng Y; Li X; Wang Y; Pan E; Guo W; Pu Y; Yin L
    Int J Mol Sci; 2013 Apr; 14(5):8899-911. PubMed ID: 23615477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential biomarkers for esophageal carcinoma detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Liu LH; Shan BE; Tian ZQ; Sang MX; Ai J; Zhang ZF; Meng J; Zhu H; Wang SJ
    Clin Chem Lab Med; 2010 Jun; 48(6):855-61. PubMed ID: 20345231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics-based identification of autoantibody against CDC25B as a novel serum marker in esophageal squamous cell carcinoma.
    Liu WL; Zhang G; Wang JY; Cao JY; Guo XZ; Xu LH; Li MZ; Song LB; Huang WL; Zeng MS
    Biochem Biophys Res Commun; 2008 Oct; 375(3):440-5. PubMed ID: 18722351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma.
    Zhang J; Wang K; Zhang J; Liu SS; Dai L; Zhang JY
    J Proteome Res; 2011 Jun; 10(6):2863-72. PubMed ID: 21517111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of galectin-7 as a potential biomarker for esophageal squamous cell carcinoma by proteomic analysis.
    Zhu X; Ding M; Yu ML; Feng MX; Tan LJ; Zhao FK
    BMC Cancer; 2010 Jun; 10():290. PubMed ID: 20546628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating levels of autoantibodies against L1-cell adhesion molecule as a potential diagnostic biomarker in esophageal squamous cell carcinoma.
    Xu YW; Peng YH; Ran LQ; Zhai TT; Guo HP; Qiu SQ; Chen HL; Wu ZY; Li EM; Xie JJ
    Clin Transl Oncol; 2017 Jul; 19(7):898-906. PubMed ID: 28181176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGFBI Expression in Cancer Stromal Cells is Associated with Poor Prognosis and Hematogenous Recurrence in Esophageal Squamous Cell Carcinoma.
    Ozawa D; Yokobori T; Sohda M; Sakai M; Hara K; Honjo H; Kato H; Miyazaki T; Kuwano H
    Ann Surg Oncol; 2016 Jan; 23(1):282-9. PubMed ID: 25448803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative tissue proteomics of esophageal squamous cell carcinoma for novel biomarker discovery.
    Pawar H; Kashyap MK; Sahasrabuddhe NA; Renuse S; Harsha HC; Kumar P; Sharma J; Kandasamy K; Marimuthu A; Nair B; Rajagopalan S; Maharudraiah J; Premalatha CS; Kumar KV; Vijayakumar M; Chaerkady R; Prasad TS; Kumar RV; Kumar RV; Pandey A
    Cancer Biol Ther; 2011 Sep; 12(6):510-22. PubMed ID: 21743296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of clusterin both in serum and tissue correlates with the tumorigenesis of esophageal squamous cell carcinoma via proteomics approaches.
    Zhang LY; Ying WT; Mao YS; He HZ; Liu Y; Wang HX; Liu F; Wang K; Zhang DC; Wang Y; Wu M; Qian XH; Zhao XH
    World J Gastroenterol; 2003 Apr; 9(4):650-4. PubMed ID: 12679903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New potential biomarkers in the diagnosis of esophageal squamous cell carcinoma.
    Xu SY; Liu Z; Ma WJ; Sheyhidin I; Zheng ST; Lu XM
    Biomarkers; 2009 Aug; 14(5):340-6. PubMed ID: 19552569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.